Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

NCT00046371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: THERATOPE® vaccine

Sponsor

Oncothyreon Canada Inc.